DMAA
Drugs Made In America Acquisition Corp
3월 13일 4:00 PM ET (한국 3/14 05:00)
$10.47
-0.02 ▼ -0.19%
🌙 3월 13일 4:10 PM ET (한국 3/14 05:10)
$10.47
+0.00 +0.00%
| Index | - | P/E | 62.14 | EPS (ttm) | 0.17 | Insider Own | 13.69% | Shs Outstand | 0.03B | Perf Week | - |
| Market Cap | 0.35B | Forward P/E | - | EPS next Y | - | Insider Trans | - | Shs Float | 0.03B | Perf Month | 0.29% |
| Enterprise Value | 0.35B | PEG | - | EPS next Q | - | Inst Own | 69.15% | Short Float | 0.1% | Perf Quarter | 1.06% |
| Income | 0.01B | P/S | - | EPS this Y | - | Inst Trans | - | Short Ratio | 0.39 | Perf Half Y | 2.15% |
| Sales | 0.00B | P/B | 1.52 | EPS next 5Y | - | ROA | 4.73% | Short Interest | 0.03M | Perf YTD | 0.92% |
| Book/sh | 6.89 | P/C | - | EPS past 3/5Y | - | ROE | 4.9% | 52W High | -0.19% ($10.49) | Perf Year | 4.8% |
| Cash/sh | 0 | P/FCF | - | Sales past 3/5Y | - | ROIC | 2.45% | 52W Low | 4.86% ($9.98) | Perf 3Y | - |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | - | Gross Margin | - | Volatility(W/M) | 0.11% 0.12% | Perf 5Y | - |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | - | ATR (14) | 0.02 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 0.06 | EPS Q/Q | 1404% | Profit Margin | - | RSI (14) | 55.11 | Recom | - |
| Dividend Gr. 3/5Y | - | Current Ratio | 0.06 | Sales Q/Q | - | SMA20 | 0.07% ($10.46) | Beta | 0 | Target Price | - |
| Payout | - | Debt/Eq | 0 | Earnings | - | SMA50 | 0.39% ($10.43) | Rel Volume | 0.07 | Prev Close | $10.49 |
| Employees | 2 | LT Debt/Eq | 0 | EPS/Sales Surpr. | - | SMA200 | 1.69% ($10.3) | Avg Volume(3M) | 0.07M | Price | $10.47 |
| IPO | 2025/2/25 | Option/Short | No/Yes | Trades | 12 | Volume | 5,093 | Change | -0.19% |
뉴스 로딩 중...